Status:
ACTIVE_NOT_RECRUITING
Written Exposure Therapy to Improve Recovery Among Sexual Assault Survivors
Lead Sponsor:
University of North Carolina, Chapel Hill
Collaborating Sponsors:
Foundation of Hope, North Carolina
US Department of Veterans Affairs
Conditions:
Post-traumatic Stress Disorder
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
The main objective of this pilot trial is to determine the feasibility and initial efficacy of telehealth-delivered written exposure therapy to reduce the development of posttraumatic stress disorder ...
Detailed Description
Each year, approximately 100,000 women in the United States present to sexual assault nurse examiner (SANE) programs for evaluation after experiencing sexual assault. A wealth of data demonstrates tha...
Eligibility Criteria
Inclusion
- Cisgender woman
- Writes and speaks English
- 18+ years of age
- Presents for SANE care within 7 days of sexual assault
- Discharged home after SANE care
- Has an email address
- Has an Apple (iOS) or Android-compatible smartphone with photo capability (for writing session upload), without loss of cellular connection due to inability to pay bill for \>1 year
- Willing to participate in remote therapy sessions
- Meets PTSD risk score criteria
- Meets with research assistant (RA) for informed consent within 30 days of SANE care
Exclusion
- Age \<18
- Pregnant
- Incarcerated or in police custody
- Presented for SANE care \>7 days after assault
- Has had a change in psychiatric medication regimen 1 month prior to study enrollment
- Currently receiving cognitive-behavioral therapy or exposure-based psychological treatment
- Sexually assaulted at work or by a colleague
- Currently lives with the person who assaulted them
- History or condition that in investigator's judgment would likely make a participant non-compliant/unsuitable for participation, including deafness or blindness
Key Trial Info
Start Date :
September 23 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2026
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06571513
Start Date
September 23 2024
End Date
March 1 2026
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina, United States, 27516